Application

15961201 · POLYMORPHIC FORMS OF NALTREXONE

Filed 2018-04-24 · Granted · Patent 10166228 (2019-01-01) The official file ↗The patent and its PDF ↗ · Art unit 1626 · Examiner Kristin Ann Vajda Easy · CPC A61K 31/485 · Alkermes Pharma Ireland Limited · Elmore Patent Law Group

Office actions

first was Notice of allowance

RCEs

no appeal

To first action

4.1 mo

to disposition 8.3 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.